Valuation: Divi's Laboratories Limited

Market Cap 2,27500Cr 2.38TCr 2.04TCr 1.9TCr 1.74TCr 3.27TCr 3.34TCr 23TCr 8.78TCr 1,14000Cr 8.93TCr 8.73TCr 3,77500Cr P/E 2027 *
70x
P/E 2028 * 58x
Enterprise Value 2,24000Cr 2.34TCr 2TCr 1.87TCr 1.72TCr 3.22TCr 3.29TCr 22TCr 8.65TCr 1,12300Cr 8.79TCr 8.6TCr 3,71700Cr EV / Sales 2027 *
17.8x
EV / Sales 2028 * 14.9x
Free-Float
48.01%
Yield 2027 *
0.41%
Yield 2028 * 0.45%
1 day-0.48%
1 week+0.61%
Current month+5.87%
1 month+16.35%
3 months+24.36%
6 months+35.51%
Current year+33.41%
1 week 8,463.5
Extreme 8463.5
8,630
1 month 7,177
Extreme 7177
8,674
Current year 5,647.5
Extreme 5647.5
8,674
1 year 5,636.5
Extreme 5636.5
8,674
3 years 3,295.3
Extreme 3295.3
8,674
5 years 2,730
Extreme 2730
8,674
10 years 532.65
Extreme 532.65
8,674
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+0.61%+41.48%+132.69% 2.38TCr
-2.81%+2.93%+76.40%+127.73% 1,10900Cr
-2.21%+2.02%+49.50%+55.01% 64TCr
-1.56%+4.39%+25.19%+74.39% 46TCr
-1.41%+3.27%+39.70%+44.20% 37TCr
-1.03%+2.19%+21.64%+39.02% 30TCr
-0.99%+4.54%-0.56%+12.24% 26TCr
-1.95%+3.80%+46.31%+65.66% 23TCr
-0.45%+0.27%-17.02%-53.14% 20TCr
-2.82%+3.84%+20.81%+89.04% 18TCr
Average -1.57%+2.79%+30.34%+58.68% 37.85TCr
Weighted average by Cap. -1.96%+3.24%+42.66%+70.37%

Financials

2027 *2028 *
Net sales 13TCr 131.33Cr 112.45Cr 104.91Cr 96Cr 180.89Cr 184.45Cr 1.24TCr 485.18Cr 6.3TCr 493.12Cr 482.39Cr 21TCr 15TCr 156.65Cr 134.12Cr 125.14Cr 114.83Cr 215.77Cr 220.01Cr 1.48TCr 578.71Cr 7.51TCr 588.18Cr 575.39Cr 25TCr
Net income 3.26TCr 34Cr 29Cr 27Cr 25Cr 47Cr 48Cr 322.57Cr 125.74Cr 1.63TCr 127.8Cr 125.02Cr 5.4TCr 3.94TCr 41Cr 35Cr 33Cr 30Cr 57Cr 58Cr 389.89Cr 151.99Cr 1.97TCr 154.48Cr 151.12Cr 6.53TCr
Net Debt -3.5TCr -37Cr -31Cr -29Cr -27Cr -50Cr -51Cr -346.65Cr -135.13Cr -1.75TCr -137.34Cr -134.35Cr -5.81TCr -4.49TCr -47Cr -40Cr -37Cr -34Cr -65Cr -66Cr -444.25Cr -173.18Cr -2.25TCr -176.01Cr -172.18Cr -7.44TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
21/26/21 8,527.50 -0.50% 1,63,299
20/26/20 ₹8,570.00 +0.12% 1,98,190
19/26/19 ₹8,560.00 -0.33% 1,79,152
18/26/18 ₹8,588.00 +1.26% 4,04,163
17/26/17 ₹8,481.50 +0.05% 2,52,029
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,570.00INR
Average target price
8,292.48INR
Spread / Average Target
-3.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock